|
"藍先元"的相关文件
显示项目 26-35 / 62 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
| 亞洲大學 |
2019-12 |
Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
|
Chieh-Hsin, L;Lin, Chieh-Hsin;Yang, Sheng;Yang, Sheng;Huan, Yu-Jhen;Huang, Yu-Jhen;藍先元;Lane, Hsien Yuan |
| 亞洲大學 |
2019-12 |
Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
|
Chieh-Hsin, L;Lin, Chieh-Hsin;Hashim, Kenji;Hashimoto, Kenji;藍先元;Lane, Hsien Yuan |
| 亞洲大學 |
2019-10 |
Novel Treatment for the hardest-to-treat Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant
|
Chieh-Hsin, L;Lin, Chieh-Hsin;Chen, Yu-Ming;Chen, Yu-Ming;藍先元;Lane, Hsien Yuan |
| 亞洲大學 |
2019-10 |
Paliperidone is associated with reduced risk of severe hepatic outcome in patients with schizophrenia and viral hepatitis: A nationwide population-based cohort study
|
CH, Chang;CH, Chang;藍先元;Lane, Hsien Yuan;CY, Liu;CY, Liu;SJ, Chen;SJ, Chen;CH, Lin;CH, Lin |
| 亞洲大學 |
2019-09 |
pLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase.
|
CH, Lin;CH, Lin;CC, Chiu;CC, Chiu;CH, Huang;CH, Huang;HT, Yang;HT, Yang;藍先元;Lane, Hsien Yuan |
| 亞洲大學 |
2019-09 |
C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia
|
CH, Chang;CH, Chang;藍先元;Lane, Hsien Yuan;CY, Liu;CY, Liu;PC, Cheng;PC, Cheng;SJ, Chen;SJ, Chen;CH, Lin;CH, Lin |
| 亞洲大學 |
2018-05 |
Brain Stimulation in Alzheimer’s Disease
|
Ch, Chun-Hung;Chang, Chun-Hung;藍先元;Lane, Hsien Yuan;Chieh-Hsin, L;Lin, Chieh-Hsin;* |
| 高雄醫學大學 |
2014 |
以肌氨酸治療高功能自閉症孩童之臨床藥物試驗
|
楊品珍;藍先元;顏正芳;張震霖 ; Yang, P;Lane, HY;Yen, CF;CL , Chang |
| 中國醫藥大學 |
2012-07-16 |
本校臨床醫學研究所參加【The 28th CINP WORLD CONGRESS OF NEUROPSYCHOPHARMACOLOGY】成果豐碩
|
藍先元 |
| 中國醫藥大學 |
2011-07 |
多巴胺系統在妥瑞症合併過動與注意力不集中症之研究
|
周宜卿; 李采娟; 蔡長海; 藍先元; 蔡輔仁 |
显示项目 26-35 / 62 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
|
